FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Flumazenil Injection, USP
Status: Discontinuation
»Therapeutic Categories: Neurology

Mylan Pharmaceuticals Inc. (New 07/19/2019)

Company Contact Information:

Presentation Posting Date Related Information
0.1mg/1ml (NDC 67457-444-10) 07/19/2019 Discontinuation of the manufacture of the drug.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English